Sneak Peek: 3 Stocks from Our Top Picks of 2026 Report
Three stocks with three very different technical backgrounds that could climb next year
Hope everyone had a lovely Christmas with friends and family. We now turn to one of the most underrated parts of the year, that murky unknown between Christmas and New Years.
I enjoy taking a “step back” these next few days, sacrificing short-term productivity for long-term vision. Instead of go-go-go, take the time to map out goals, trips, resolutions, stuff to stop doing, stuff to start doing more of. The point of the audit is to empty the notebook, leave no stone unturned.
Groundbreaking, I know: plan ahead and use time wisely. But hey, you’d be surprised at how people slip up at the easy things these days. Fund the mentals!
With that in mind, these last few posts of the year will be all about emptying the notebook on the year and looking ahead.
To help you plan out your long term, ‘buy-and-hold’ thesis for 2026, our Top Stock Picks of 2026 is now out. But below are three picks from the report to get a head start.
To sign up for the entirety of the report, click here.
Cameco (CCJ)
Uranium producer Cameco (CCJ) has benefited from the increased demand for alternate energy sources, with many experts betting on the future of nuclear power.
Where have I heard that before…
Someone has to power all these the data centers and AI projects that have been growing like weeds in the last 12 months. The Trump administration is all in, and any number of geopolitical risks in 2026 could ramp up demand even more.
CCJ is currently up over 80% year to date, breaking out of a range between $35 and $60 where it spent most of 2024. So it’s not cheap. But the equity is consolidating above this region and —with its uptrend channel intact — could be gearing up for the next leg higher.
The stock doesn’t have much going for it from a contrarian perspective—there’s little short squeeze or analyst shift that could provide tailwinds. Oklo (OKLO) and Nuscale Power (SMR) took up all the oxygen around the sector in 2025. But remember; those companies are reactors, not uranium producers.
Cameco is the world’s largest uranium producer by market cap, at $40 billion. The next highest U.S. company? BWX Technologies (BWX), at $16.19. Think of CCJ as a type of ‘gold miner’ play, where if you don’t want to go all in on gold, play the boom from the background with the miners. This could be the Newmont stock of 2026.
GigaCloud Technology (GCT)
GigaCloud Technology wins points just for its cool-sounding name. The e-commerce company streamlines business-to-business marketplaces and helps supply chain efficiency.
The stock broke through a downtrend in late 2025 with help from its 2024 highs and is now rising alongside support from its 20-day moving average. The shares boast an 112% lead for the year, but are still a 20-, 50-, and 60-day relative strength (RS) leader.
GCTI notched a fresh 52-week peak in December after clearing $36.75, which is three times its August 2022 initial public offering (IPO) price of $12.25. Additional analyst attention could create tailwinds, as only five analysts are currently in coverage and the consensus 12-month price target of $37.25 is a 7% discount to its Friday close. A short squeeze could come into play as well, with GCT’s StarMine short squeeze score ranking at 89 out of 100. Short interest down 19% in the most recent reporting period, yet the 2.62 million shares sold short still accounts for a healthy 10.2% of the stock’s available float.
Once there’s a sustainable move above $40, we could be off to the races.
Bristol-Myers Squibb (BMY)
The first two stocks (and spoiler, most of the report) are outperformers with room to run.
Not BMY. The drug stock has rallied to end the year but will likely finish below its 2025 breakeven level. But the rally off those late October lows below $30 means something.
If interest rates are lower or stable in 2026, capital reallocates from high-multiple growth names to long-duration, cash generative equities. BMY could stand to benefit from this rotation, screening extremely well on free cashflow yield and dividend sustainability. Thanks to this rotation starting at the end of 2025, BMY has reclaimed its 200-month moving average, as well as a long-term trendline connecting higher highs from 2004-2012.
The shares could test their March 2025 highs of $63, nearly 18% upside from this report. If that peak doesn’t cap sustained moves higher, there is as much as a 40% upside towards its former long-term high at $75, which could be attained in the next 12 months.
A Schaeffer’s put/call open interest ratio (SOIR) of 1.12 sitting in the 92nd percentile of its annual range shows a skew toward short-term bearish bets. And with a Schaeffer's Volatility Scorecard (SVS) of 13 out of 100, BMY has consistently realized lower volatility than its options have priced in, so a premium-selling strategy could be the move for options traders.
Three stocks, three different sectors, three entirely different technical backdrops. That’s the goal of our long-term Top Stock Pick report every year, to ensure a variety of trades are represented.
We’ll see you next week when we revisit our 2025 picks.